Jordan Zwick
CORPORATE DIRECTOR
Jordan Zwick is currently Chief Business Officer and one of the founding team members at Mirador Therapeutics.
He also served as strategic advisor to Prometheus Biosciences prior to its sale to Merck in June 2023.
Previously, Mr. Zwick served as SVP, Corporate Business Development and Investor Relations at Amarin Corp (AMRN), closing multiple transactions for global partnering of the lead asset. Jordan served as SVP, Chief Strategy Officer at InflaRx N.V. (IFRX), where he was responsible for leading corporate strategy, business & corporate development, investor relations and was instrumental in the public financings of the Company.
Mr. Zwick holds B.A., M.S. degrees from Florida Atlantic University and a M.B.A. from the University of San Francisco.